Prediction of High‐Risk Cytogenetic Status in Multiple Myeloma Based on Magnetic Resonance Imaging: Utility of Radiomics and Comparison of Machine Learning Methods
- 12 May 2021
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 54 (4) , 1303-1311
Abstract
Background: Radiomics has shown promising results in the diagnosis, efficacy, and prognostic assessments of multiple myeloma (MM). However, little evidence exists on the utility of radiomics in predicting a high‐risk cytogenetic (HRC) status in MM.Purpose: To develop and test a magnetic resonance imaging (MRI)‐based radiomics model for predicting an HRC status in MM patients.Study Type: Retrospective.Population: Eighty‐nine MM patients (HRC [n: 37] and non‐HRC [n: 52]).Field Strength/Sequence: A 3.0 T; fast spin‐echo (FSE): T1‐weighted image (T1WI) and fat‐suppression T2WI (FS‐T2WI).Assessment: Overall, 1409 radiomics features were extracted from each volume of interest drawn by radiologists. Three sequential feature selection steps—variance threshold, SelectKBest, and least absolute shrinkage selection operator—were repeated 10 times with 5‐fold cross‐validation. Radiomics models were constructed with the top three frequency features of T1WI/T2WI/two‐sequence MRI (T1WI and FS‐T2WI). Radiomics models, clinical data (age and visually assessed MRI pattern), or radiomics combined with clinical data were used with six classifiers to distinguish between HRC and non‐HRC statuses. Six classifiers used were support vector machine, random forest, logistic regression (LR), decision tree, k‐nearest neighbor, and XGBoost. Model performance was evaluated with area under the curve (AUC) values.Statistical Tests: Mann–Whitney U‐test, Chi‐squared test, Z test, and DeLong method.Results: The LR classifier performed better than the other classifiers based on different data (AUC: 0.65–0.82; P < 0.05). The two‐sequence MRI models performed better than the other data models using different classifiers (AUC: 0.68–0.82; P < 0.05). Thus, the LR two‐sequence model yielded the best performance (AUC: 0.82 ± 0.02; sensitivity: 84.1%; specificity: 68.1%; accuracy: 74.7%; P < 0.05).Conclusion: The LR‐based machine learning method appears superior to other classifier methods for assessing HRC in MM. Radiomics features based on two‐sequence MRI showed good performance in differentiating HRC and non‐HRC statuses in MM.Evidence Level: 3Technical Efficacy: Stage 2Keywords
Funding Information
- National Natural Science Foundation of China (81871326, 81971578)
This publication has 28 references indexed in Scilit:
- Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patientsBMC Cancer, 2018
- Multiple myeloma: 2016 update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2016
- A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability ResearchJournal of Chiropractic Medicine, 2016
- Radiomics: Images Are More than Pictures, They Are DataRadiology, 2016
- International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaThe Lancet Oncology, 2014
- Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: A single center experience on 228 patientsAmerican Journal of Hematology, 2012
- Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus GuidelinesMayo Clinic Proceedings, 2009
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease.Radiology, 1992
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975